Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer

NCT00052728 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: tamoxifen citrate
DRUG: tipifarnib

Sponsor

National Cancer Institute (NCI)